BRD2 and bone cancer: Another three studies focused on multiple cancer types (e.g. breast cancer, endometrial cancer, brain cancer, and bone cancer) (Das et al., 2011; Naasan et al., 2016; Gunnala et al., 2019), for which serum AMH, basal FSH, and AFC were reported, respectively.